Showing results (151-160 of 289) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2010
Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samplesVera L Costa, Rui Henrique, Stine A Danielsen, et al.
Frontiers in Oncology|May 21, 2026
ATG16L1 and OPTN as a novel prognostic gene expression signature in acute myeloid leukemia survivalAlexandra Teixeira, João M Alves, Nuria Estévez-Gómez, et al.
Neoplasia (New York, N.Y.)|August 21, 2012
Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangementsPaula Paulo, Franclim R Ribeiro, Joana Santos, et al.
Virchows Archiv : an International Journal of Pathology|May 4, 2025
P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinomaRita Canário, Ana Sofia Ribeiro, Inês Morgado, et al.
BMC Cancer|June 14, 2012
Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletionAmanda Gonçalves Silva, Ingrid Petroni Ewald, Marina Sapienza, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 31, 2012
EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective studyRamon Andrade de Mello, Filipa Soares Pires, Dânia Sofia Marques, et al.
Familial Cancer|October 14, 2020
The role of TP53 pathogenic variants in early-onset HER2-positive breast cancerCarla Escudeiro, Carla Pinto, Joana Vieira, et al.
BMC Cancer|October 29, 2010
Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of originManuela Pinheiro, Terje Ahlquist, Stine A Danielsen, et al.
Familial Cancer|May 27, 2009
TP53 germline mutations in Portugal and genetic modifiers of age at cancer onsetCarla Pinto, Isabel Veiga, Manuela Pinheiro, et al.
Frontiers in Oncology|August 28, 2020
Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder EffectsAna Peixoto, Pedro Pinto, Joana Guerra, et al.
Pageof 29